Angiopoietin-2 — Drug Target
All drugs that target Angiopoietin-2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (1)
- AMG 386 with or without Trastuzumab · QuantumLeap Healthcare Collaborative · Angiopoietin-2 inhibitor · Oncology
AMG 386 is an angiopoietin-2 (Ang-2) inhibitor that works by binding to Ang-2 and preventing its interaction with its receptor, thereby inhibiting angiogenesis.
Phase 1 pipeline (1)
- AMG 386, paclitaxel and carboplatin · Amgen · Angiopoietin-2 inhibitor · Oncology
Angiopoietin-2 inhibitor